# RESPONSE BIOMEDICAL CORP

RESPONSE BIOMEDICAL CORP is a company headquartered in Vancouver, Canada.

## Company overview

- **Legal name:** RESPONSE BIOMEDICAL CORP
- **Classification:** Company
- **Industry (SIC):** 8734 — Services-Testing Laboratories
- **Headquarters:** Vancouver, Canada
- **Incorporated in:** A1
- **Fiscal year end:** December 31
- **SEC CIK:** 0000806888

## About

RESPONSE BIOMEDICAL CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000806888, and its reported industry is Services-Testing Laboratories. In 10-K filed on 2016-03-24, it reported annual revenue of CAD 15,418,000; net income of CAD -150,000; total assets of CAD 11,806,000 for the fiscal period ended 2015-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-12-31)

- **Revenue:** CAD 15.4M (CAD 15,418,000)
- **Net income:** -CAD 150,000 (CAD -150,000)
- **Total assets:** CAD 11.8M (CAD 11,806,000)
- **Cash and equivalents:** CAD 2.5M (CAD 2,511,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2014 (period ended 2014-12-31)

- **Revenue:** CAD 11.0M (CAD 11,014,000)
- **Net income:** -CAD 2.1M (CAD -2,090,000)
- **Total assets:** CAD 13.6M (CAD 13,628,000)
- **Cash and equivalents:** CAD 3.2M (CAD 3,221,000)
- **Operating cash flow:** -CAD 2.3M (CAD -2,281,000)

### FY2013 (period ended 2013-12-31)

- **Net income:** -CAD 6.0M (CAD -5,998,000)
- **Total assets:** CAD 14.2M (CAD 14,204,000)
- **Cash and equivalents:** CAD 3.0M (CAD 2,958,000)
- **Operating cash flow:** -CAD 1.3M (CAD -1,274,000)

### FY2012 (period ended 2012-12-31)

- **Net income:** -CAD 5.3M (CAD -5,280,917)
- **Total assets:** CAD 14.3M (CAD 14,347,781)
- **Cash and equivalents:** CAD 2.1M (CAD 2,079,718)
- **Operating cash flow:** -CAD 4.6M (CAD -4,632,294)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2016-12-02 — period 2016-11-29 — FORM 8-K
- Form 8-K — filed 2016-11-15 — period 2016-11-10 — FORM 8-K
- Form 10-Q — filed 2016-11-14 — period 2016-09-30 — FORM 10-Q
- Form 8-K — filed 2016-09-21 — period 2016-09-16 — FORM 8-K
- Form 8-K — filed 2016-08-16 — period 2016-08-12 — FORM 8-K
- Form 10-Q — filed 2016-08-15 — period 2016-06-30 — FORM 10-Q
- Form 8-K — filed 2016-06-20 — period 2016-06-16 — FORM 8-K
- Form 8-K — filed 2016-06-15 — period 2016-06-13 — FORM 8-K
- Form 8-K — filed 2016-05-19 — period 2016-05-16 — FORM 8-K
- Form 10-Q — filed 2016-05-16 — period 2016-03-31 — FORM 10-Q
- Form DEF 14A — filed 2016-05-13 — period 2016-06-13 — FORM DEF 14A
- Form 10-K/A — filed 2016-04-29 — period 2015-12-31 — FORM 10-K/A

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/response-biomedical-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology